Novogen - 9 Year Dividend History | KZIA
Historical dividend payout and yield for Novogen (KZIA) since 2015. The current TTM dividend payout for Novogen (KZIA) as of April 17, 2024 is $0.00. The current dividend yield for Novogen as of April 17, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.005B |
$0.000B |
|
Kazia Therapeutics Limited is an oncology-focused biotechnology company. It develops anti-cancer drugs as well as provides pharmaceutical research and development technology solutions. The company's lead program is GDC-0084, a small molecule inhibitor of the PI3K / AKT / mTOR pathway, which is being developed to treat glioblastoma multiforme, the primary and most aggressive form of brain cancer. Kazia Therapeutics Limited, formerly known as Novogen Limited, is based in Sydney, Australia.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
